BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hussain HK, Syed I, Nghiem HV, Johnson TD, Carlos RC, Weadock WJ, Francis IR. T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology. 2004;230:637-644. [PMID: 14739306 DOI: 10.1148/radiol.2303020921] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim TK, Lee E, Jang HJ. Imaging findings of mimickers of hepatocellular carcinoma. Clin Mol Hepatol 2015;21:326-43. [PMID: 26770920 DOI: 10.3350/cmh.2015.21.4.326] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
2 Rosenkrantz AB, Mannelli L, Kim S, Babb JS. Gadolinium-Enhanced Liver Magnetic Resonance Imaging Using a 2-Point Dixon Fat-Water Separation Technique: Impact Upon Image Quality and Lesion Detection. Journal of Computer Assisted Tomography 2011;35:96-101. [DOI: 10.1097/rct.0b013e3181f3d57e] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Khatri G, Merrick L, Miller FH. MR imaging of hepatocellular carcinoma. Magn Reson Imaging Clin N Am. 2010;18:421-450, x. [PMID: 21094448 DOI: 10.1016/j.mric.2010.08.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
4 Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB. Liver Fibrosis: Noninvasive Diagnosis with Double Contrast Material–enhanced MR Imaging. Radiology 2006;239:425-37. [DOI: 10.1148/radiol.2392050505] [Cited by in Crossref: 143] [Cited by in F6Publishing: 135] [Article Influence: 8.9] [Reference Citation Analysis]
5 Lee HY, Lee JM, Kim SH, Shin KS, Lee JY, Han JK, Choi BI. Detection and characterization of focal hepatic lesions by T2-weighted imaging: comparison of navigator-triggered turbo spin-echo, breath-hold turbo spin-echo, and HASTE sequences. Clinical Imaging 2009;33:281-8. [DOI: 10.1016/j.clinimag.2008.10.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Hughes-Cassidy F, Chavez AD, Schlang A, Hassanein T, Gamst A, Wolfson T, Sirlin C. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis. J Magn Reson Imaging. 2007;26:728-737. [PMID: 17685418 DOI: 10.1002/jmri.21066] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
7 Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, Taouli B. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology. 2008;246:812-822. [PMID: 18223123 DOI: 10.1148/radiol.2463070432] [Cited by in Crossref: 401] [Cited by in F6Publishing: 353] [Article Influence: 28.6] [Reference Citation Analysis]
8 Cerny M, Chernyak V, Olivié D, Billiard J, Murphy-lavallée J, Kielar AZ, Elsayes KM, Bourque L, Hooker JC, Sirlin CB, Tang A. LI-RADS Version 2018 Ancillary Features at MRI. RadioGraphics 2018;38:1973-2001. [DOI: 10.1148/rg.2018180052] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
9 Wang D, Zhang ZR, Li YY, Yan WY, Zhao DL, Wan Y. Advances in imaging diagnosis of Budd-Chiari syndrome. Shijie Huaren Xiaohua Zazhi 2008; 16(7): 746-750 [DOI: 10.11569/wcjd.v16.i7.746] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Coenegrachts K, Delanote J, Ter Beek L, Haspeslagh M, Bipat S, Stoker J, Van Kerkhove F, Steyaert L, Rigauts H, Casselman JW. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol. 2007;80:524-531. [PMID: 17510250 DOI: 10.1259/bjr/33156643] [Cited by in Crossref: 111] [Cited by in F6Publishing: 101] [Article Influence: 7.4] [Reference Citation Analysis]
11 Mallett S, Halligan S, Collins GS, Altman DG. Exploration of analysis methods for diagnostic imaging tests: problems with ROC AUC and confidence scores in CT colonography. PLoS One 2014;9:e107633. [PMID: 25353643 DOI: 10.1371/journal.pone.0107633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr. 2010;34:506-512. [PMID: 20657216 DOI: 10.1097/rct.0b013e3181da3671] [Cited by in Crossref: 80] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
13 Shin SK, Kim YS, Choi SJ, Shim YS, Jung DH, Kwon OS, Choi DJ, Kim JH. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article. Medicine (Baltimore) 2017;96:e7278. [PMID: 28723741 DOI: 10.1097/MD.0000000000007278] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005;237:938-44. [PMID: 16306035 DOI: 10.1148/radiol.2373041364] [Cited by in Crossref: 125] [Cited by in F6Publishing: 112] [Article Influence: 7.8] [Reference Citation Analysis]
15 Wang H, Wang XY, Jiang XX, Ye ZX. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T. Acad Radiol 2010;17:239-43. [PMID: 19962912 DOI: 10.1016/j.acra.2009.09.012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
16 Le Moigne F, Durieux M, Bancel B, Boublay N, Boussel L, Ducerf C, Berthezène Y, Rode A. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. Magnetic Resonance Imaging 2012;30:656-65. [DOI: 10.1016/j.mri.2012.01.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
17 Renzulli M, Brandi N, Argalia G, Brocchi S, Farolfi A, Fanti S, Golfieri R. Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions. Radiol Med 2022. [PMID: 35028886 DOI: 10.1007/s11547-022-01449-w] [Reference Citation Analysis]
18 Dujardin M, Vandenbroucke F, Boulet C, Op de Beeck B, de Mey J. Indications for body MRI. European Journal of Radiology 2008;65:214-21. [DOI: 10.1016/j.ejrad.2007.11.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
19 Kovac JD, Ivanovic A, Milovanovic T, Micev M, Alessandrino F, Gore RM. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation. Radiol Oncol 2021;55:130-43. [PMID: 33544992 DOI: 10.2478/raon-2021-0004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Park YN, Kim MJ. Hepatocarcinogenesis: imaging-pathologic correlation. Abdom Imaging. 2011;36:232-243. [PMID: 21267560 DOI: 10.1007/s00261-011-9688-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
21 Khan AS, Hussain HK, Johnson TD, Weadock WJ, Pelletier SJ, Marrero JA. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver. J Magn Reson Imaging. 2010;32:360-366. [PMID: 20677263 DOI: 10.1002/jmri.22271] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 7.1] [Reference Citation Analysis]
22 Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology. 2008;247:311-330. [PMID: 18430871 DOI: 10.1148/radiol.2472061331] [Cited by in Crossref: 274] [Cited by in F6Publishing: 233] [Article Influence: 19.6] [Reference Citation Analysis]
23 Granata V, Fusco R, Avallone A, Catalano O, Filice F, Leongito M, Palaia R, Izzo F, Petrillo A. Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update. Infect Agent Cancer 2017;12:23. [PMID: 28465718 DOI: 10.1186/s13027-017-0132-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
24 Sofue K, Burke LM, Nilmini V, Alagiyawanna M, Muir AJ, Choudhury KR, Jaffe TA, Semelka RC, Bashir MR. Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5: LI-RADS Category 4 Observations in MRI. J Magn Reson Imaging 2017;46:783-92. [DOI: 10.1002/jmri.25627] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
25 Thompson SM, Garg I, Ehman EC, Sheedy SP, Bookwalter CA, Carter RE, Roberts LR, Venkatesh SK. Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI. Br J Radiol 2018;91:20180345. [PMID: 30074820 DOI: 10.1259/bjr.20180345] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
26 Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, West AB, Babb JS, Taouli B, Lee VS, Krinsky GA. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis. Radiology. 2006;239:438-447. [PMID: 16641353 DOI: 10.1148/radiol.2392050551] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 5.9] [Reference Citation Analysis]
27 Ramalho M, Matos AP, AlObaidy M, Velloni F, Altun E, Semelka RC. Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2. Radiol Bras 2017;50:115-25. [PMID: 28428655 DOI: 10.1590/0100-3984.2015.0140] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 Papadatos D, Fowler KJ, Kielar AZ, Cui J, Sirlin CB. Cirrhosis and LI-RADS. Abdom Radiol (NY) 2018;43:26-40. [PMID: 29218367 DOI: 10.1007/s00261-017-1425-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Xu K, Ren K, Chen Y. Application and evaluation of non-invasive examination for Budd-Chiari syndrome: . Chinese Medical Journal 2007;120:91-4. [DOI: 10.1097/00029330-200701020-00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Brancatelli G, Baron RL, Federle MP, Sparacia G, Pealer K. Focal Confluent Fibrosis in Cirrhotic Liver: Natural History Studied with Serial CT. American Journal of Roentgenology 2009;192:1341-7. [DOI: 10.2214/ajr.07.2782] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
31 Hyodo T, Murakami T, Imai Y, Okada M, Hori M, Kagawa Y, Kogita S, Kumano S, Kudo M, Mochizuki T. Hypovascular nodules in patients with chronic liver disease: risk factors for development of hypervascular hepatocellular carcinoma. Radiology. 2013;266:480-490. [PMID: 23362095 DOI: 10.1148/radiol.12112677] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]
32 Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS. Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl. 2005;11:281-289. [PMID: 15719410 DOI: 10.1002/lt.20357] [Cited by in Crossref: 169] [Cited by in F6Publishing: 142] [Article Influence: 9.9] [Reference Citation Analysis]
33 Barr DC, Hussain HK. MR Imaging in Cirrhosis and Hepatocellular Carcinoma. Magnetic Resonance Imaging Clinics of North America 2014;22:315-35. [DOI: 10.1016/j.mric.2014.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
34 Renzulli M, Brocchi S, Ierardi AM, Milandri M, Pettinari I, Lucidi V, Balacchi C, Muratori P, Marasco G, Vara G, Tovoli F, Granito A, Carrafiello G, Piscaglia F, Golfieri R. Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver. Magn Reson Imaging 2021;75:9-20. [PMID: 32926993 DOI: 10.1016/j.mri.2020.09.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Yu JS, Lee JH, Park MS, Kim KW. Hyperintense nodules on non-enhanced T1-weighted gradient-echo magnetic resonance imaging of cirrhotic liver: fate and clinical implications. J Magn Reson Imaging. 2006;24:630-636. [PMID: 16888794 DOI: 10.1002/jmri.20674] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
36 Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, Han JK, Choi BI. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol. 2008;43:202-210. [PMID: 18301317 DOI: 10.1097/rli.0b013e31815d6929] [Cited by in Crossref: 60] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
37 Chen ML, Zhang XY, Qi LP, Shi QL, Chen B, Sun YS. Diffusion-weighted images (DWI) without ADC values in assessment of small focal nodules in cirrhotic liver. Chin J Cancer Res. 2014;26:38-47. [PMID: 24653625 DOI: 10.3978/j.issn.1000-9604.2014.01.07] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
38 Wheaton AJ, Borthakur A, Corbo MT, Moonis G, Melhem E, Reddy R. T2rho-weighted contrast in MR images of the human brain. Magn Reson Med 2004;52:1223-7. [PMID: 15562499 DOI: 10.1002/mrm.20284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
39 Barr DC, Hussain HK. Magnetic Resonance Imaging in Cirrhosis: What’s New? Topics in Magnetic Resonance Imaging 2014;23:129-49. [DOI: 10.1097/rmr.0000000000000017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Ren K, Xu K, Sun W, Chen Y, Qi X, Li R, Jin A. Preliminary evaluation of magnetic resonance fresh blood imaging for diagnosis of Budd-Chiari syndrome: . Chinese Medical Journal 2007;120:95-9. [DOI: 10.1097/00029330-200701020-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
41 Byrnes V, Shi H, Kiryu S, Rofsky NM, Afdhal NH. The Clinical Outcome of Small (<20 mm) Arterially Enhancing Nodules on MRI in the Cirrhotic Liver. Am J Gastroenterology 2007;102:1654-9. [DOI: 10.1111/j.1572-0241.2007.01338.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
42 Hirata K, Nakaura T, Okuaki T, Tsuda N, Taguchi N, Oda S, Utsunomiya D, Yamashita Y. 3D hybrid profile order technique in a single breath-hold 3D T2-weighted fast spin-echo sequence: Usefulness in diagnosis of small liver lesions. European Journal of Radiology 2018;98:113-7. [DOI: 10.1016/j.ejrad.2017.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Griffin N, Addley H, Sala E, Shaw AS, Grant LA, Eldaly H, Davies SE, Prevost T, Alexander GJ, Lomas DJ. Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI? Br J Radiol 2012;85:736-44. [PMID: 21385912 DOI: 10.1259/bjr/94924398] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
44 Parikh A, Taouli B. Imaging of hepatocellular carcinoma: current concepts. Recent Results Cancer Res. 2013;190:33-55. [PMID: 22941012 DOI: 10.1007/978-3-642-16037-0_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
45 Qu JR, Li HL, Shao NN, Li X, Yan GL, Zhang HK, Luo JP, Zhang SN, Li YL, Liu CC. Additional diffusion-weighted imaging in the detection of new, very small hepatocellular carcinoma lesions after interventional therapy compared with conventional 3 T MRI alone. Clin Radiol 2012;67:669-74. [PMID: 22336669 DOI: 10.1016/j.crad.2011.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
46 Wile GE, Leyendecker JR. Magnetic resonance imaging of the liver: sequence optimization and artifacts. Magn Reson Imaging Clin N Am 2010;18:525-47, xi. [PMID: 21094454 DOI: 10.1016/j.mric.2010.07.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
47 Xu PJ, Yan FH, Wang JH, Lin J, Ji Y. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. J Magn Reson Imaging. 2009;29:341-349. [PMID: 19161186 DOI: 10.1002/jmri.21650] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 5.9] [Reference Citation Analysis]
48 Bahl G, Cruite I, Wolfson T, Gamst AC, Collins JM, Chavez AD, Barakat F, Hassanein T, Sirlin CB. Noninvasive classification of hepatic fibrosis based on texture parameters from double contrast-enhanced magnetic resonance images. J Magn Reson Imaging 2012;36:1154-61. [PMID: 22851409 DOI: 10.1002/jmri.23759] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
49 Puneet P, Perera MTPR, Mirza DF. Current opinion on the role of resection and liver transplantation for hepatocellular cancer. Indian J Gastroenterol 2012;31:89-99. [DOI: 10.1007/s12664-012-0200-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
50 Niendorf E, Spilseth B, Wang X, Taylor A. Contrast Enhanced MRI in the Diagnosis of HCC. Diagnostics (Basel). 2015;5:383-398. [PMID: 26854161 DOI: 10.3390/diagnostics5030383] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
51 Phongkitkarun S, Limsamutpetch K, Tannaphai P, Jatchavala J. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients. World J Gastroenterol 2013; 19(45): 8357-8365 [PMID: 24363528 DOI: 10.3748/wjg.v19.i45.8357] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
52 Saar B, Kellner-Weldon F. Radiological diagnosis of hepatocellular carcinoma. Liver Int. 2008;28:189-199. [PMID: 18251978 DOI: 10.1111/j.1478-3231.2007.01655.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
53 Kim YK, Lee YH, Kim CS, Han YM. Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas. Eur J Radiol. 2008;67:304-310. [PMID: 17714904 DOI: 10.1016/j.ejrad.2007.07.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
54 Guo L, Liang C, Yu T, Wang G, Li N, Sun H, Gao F, Liu C. 3 T MRI of hepatocellular carcinomas in patients with cirrhosis: does T2-weighted imaging provide added value? Clin Radiol. 2012;67:319-328. [PMID: 22099524 DOI: 10.1016/j.crad.2011.08.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
55 Lee SS, Byun JH, Hong H, Park SH, Won HJ, Shin YM, Lee M. Image quality and focal lesion detection on T2-weighted MR imaging of the liver: Comparison of two high-resolution free-breathing imaging techniques with two breath-hold imaging techniques. J Magn Reson Imaging 2007;26:323-30. [DOI: 10.1002/jmri.21002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
56 Kim JE, Kim SH, Lee SJ, Rhim H. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol. 2011;196:W758-W765. [PMID: 21606265 DOI: 10.2214/ajr.10.4394] [Cited by in Crossref: 79] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
57 Berbaum KS. God, like the Devil, is in the details. Acad Radiol 2006;13:1311-6. [PMID: 17070448 DOI: 10.1016/j.acra.2006.09.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Kanematsu M, Goshima S. Does T2-weighted MR Imaging Really Add No Value in Detection and Characterization of Focal Lesions in Cirrhotic Liver? Radiology 2005;234:638-40. [DOI: 10.1148/radiol.2342041419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
59 Glockner JF. Hepatobiliary MRI: current concepts and controversies. J Magn Reson Imaging. 2007;25:681-695. [PMID: 17352396 DOI: 10.1002/jmri.20844] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
60 Kang KA, Kim YK, Kim E, Jeong WK, Choi D, Lee WJ, Jung SH, Baek SY. T2-Weighted Liver MRI Using the MultiVane Technique at 3T: Comparison with Conventional T2-Weighted MRI. Korean J Radiol 2015;16:1038-46. [PMID: 26357498 DOI: 10.3348/kjr.2015.16.5.1038] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
61 Choi MH, Choi JI, Lee YJ, Park MY, Rha SE, Lall C. MRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm. AJR Am J Roentgenol 2017;208:544-51. [PMID: 28026208 DOI: 10.2214/AJR.16.16414] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
62 Qian LX, Liu YJ, Ding HG. Advances in imaging diagnosis of small hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(5): 479-486 [DOI: 10.11569/wcjd.v18.i5.479] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
63 Hwang J, Kim YK, Jeong WK, Choi D, Rhim H, Lee WJ. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization. Radiology. 2015;276:137-146. [PMID: 25734551 DOI: 10.1148/radiol.15141350] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
64 Yang DW, Wang KY, Yao X, Ye HY, Jiang T, Liu Y, Gao JY, Chen M, Zhou C, Yang ZH. Diffusion-Weighted Imaging with Two Different b-Values in Detection of Solid Focal Liver Lesions. Biomed Res Int 2016;2016:8128207. [PMID: 27019851 DOI: 10.1155/2016/8128207] [Reference Citation Analysis]
65 Hennedige T, Venkatesh SK. Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring. Cancer Imaging. 2013;12:530-547. [PMID: 23400006 DOI: 10.1102/1470-7330.2012.0044] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
66 Elsayes KM, Leyendecker JR, Menias CO, Oliveira EP, Narra VR, Chapman WC, Hassanien MH, Elsharkawy MS, Brown JJ. MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility. HPB (Oxford) 2007;9:208-15. [PMID: 18333224 DOI: 10.1080/13651820701216950] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]